E-Mail
BOSTON Obesity increases one s risk for many diseases and often prevents patients from receiving other necessary medical procedures. One of the most effective ways for patients with severe obesity to lose weight is through bariatric surgery, but it s not clear how often this option is raised. In a new study published in
Obesity, investigators from Brigham and Women s Hospital find that eligible patients who discuss bariatric surgery options with their primary care providers or specialists from disciplines ranging from cardiology to urology are more likely to undergo surgery and lose more weight than those who do not have such discussions. But the team also found that these pivotal discussions were exceedingly rare, with fewer than 10 percent of eligible patients having a conversation over the course of a year.
On May 12, 2021, the Institute for Clinical and Economic Review (ICER or the Institute) released plans to begin an annual examination into health insurance drug coverage policies to.
The nonprofit Patent-Centered Outcomes Research Institute, which funds clinical research, is also relocating to the building.
Both are large leases. The ABA is leasing more than 87,000 square feet across three floors, and will relocate from its current headquarters about four blocks away at 1120 Connecticut Avenue, NW. It won’t move until November of 2022.
PCORI is leasing 96,000 square feet across three-and-a-half floors, moving from 1828 L Street, NW, and consolidating several other locations. It will relocate in Spring of 2022.
Combined, the two are leasing more than half of the 12-story building, owned by Bethesda, Maryland-based The Meridian Group, and bringing the building to 73% leased. The building is currently in the final stages of its major renovation.
Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer Sanofi partnering with the Breast International Group (BIG), the European Organization for Research and Treatment of Cancer (EORTC) and.